Showing 1 - 20 results of 27 for search 'S. V. Eremeeva', query time: 0.03s
Refine Results
-
1
Пріоритетні напрями модернізації правового забезпечення сталого інвестування by N. V. Eremeeva
Published 2025-06-01Get full text
Article -
2
-
3
APPLICATION OF STEM CELLS AND PRECURSOR CELLS FOR STIMULATION OF ORGAN REVASCULARIZATION AND REGENERATION by M. V. Eremeeva
Published 2010-06-01Get full text
Article -
4
-
5
Rheumatic manifestations of hypothyroidism by L. V. Teplova, A. V. Eremeeva, O. A. Baykova, N. A. Suvorova
Published 2017-04-01Get full text
Article -
6
T-bet syndrome-associated bronchial asthma phenotype by L. N. Sorokina, V. N. Mineev, A. V. Eremeeva, M. A. Nyoma
Published 2020-01-01Get full text
Article -
7
Influence of biologicaly active plant of kind solanaceae in phytopathogenic fungi by I. K. Aibulatova, O. V. Iagodkina, S. V. Eremeeva, V. E. Аfanasev
Published 2015-02-01Get full text
Article -
8
Scientific and clinical studies in laryngology and phoniatrics at the Department of ear, nose and throat diseases I.M. Sechenov First Moscow State Medical University: the continuit... by V. M. Svistushkin, S. V. Starostina, E. B. Rakunova, L. V. Eremeeva, E. Ye. Avetisyan
Published 2016-12-01Get full text
Article -
9
-
10
-
11
-
12
Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study by T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaydukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Eremeeva, M. A. Morozova
Published 2020-11-01Get full text
Article -
13
The treatment of drug-induced rhinitis with an original intranasal combination: Efficacy and safety in experimental animals by E. A. Smolyarchuk, Xi Yang, V. M. Svistushkin, K. V. Eremeeva, Zh. M. Kozlova, D. A. Kudlay, A. S. Machikhin, A. V. Guryleva, D. A. Derevesnikova, A. A. Nedorubov
Published 2025-08-01Get full text
Article -
14
Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study by T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaydukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Zinkina-Orikhan, Yu. A. Sevastyanova, A. V. Eremeeva
Published 2021-03-01Get full text
Article -
15
Netakimab for the treatment of psoriatic arthritis: 3-year results of the phase III BCD-085-8/PATERA study by T. V. Korotaeva, V. I. Mazurov, A. M. Lila, I. Z. Gaidukova, A. L. Bakulev, A. V. Samtsov, V. R. Khairutdinov, A. V. Zinkina-Orikhan, Yu. N. Linkova, A. V. Eremeeva
Published 2024-08-01Get full text
Article -
16
Efficacy and safety of levilimab in combination with methotrexate in subjects with rheumatoid arthritis: Results of phase II AURORA study by V. I. Mazurov, E. G. Zotkin, I. Z. Gaydukova, E. P. Ilivanova, T. V. Kropotina, T. V. Plaksina, O. B. Nesmeyanova, N. F. Soroka, E. A. Kunder, E. A. Dokukina, Yu. N. Linkova, N. A. Kravtsova, P. S. Pukhtinskaya, A. V. Eremeeva, A. V. Zinkina-Orikhan, A. A. Lutckii
Published 2021-05-01Get full text
Article -
17
THE RESULTS OF A PHASE III COMPARATIVE CLINICAL TRIAL OF RITUXIMAB (ACELLBIA® AND MABTHERA®) IN RHEUMATOID ARTHRITIS (THE BIORA STUDY) by E. L. Nasonov, E. V. Zonova, O. N. Ivanova, L. A. Knyazeva, V. I. Mazurov, R. R. Samigullina, I. M. Marusenko, O. B. Nesmeyanova, T. V. Plaksina, A. E. Sizikov, D. G. Krechikova, N. A. Petrochenkova, Yu. S. Shapovalova, N. S. Soroka, S. I. Pimanov, A. M. Pristrom, E. V. Kunder, E. V. Chernyaeva, A. V. Eremeeva, R. Ivanov
Published 2016-12-01Get full text
Article -
18
Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, doub... by D. E. Karateev, V. I. Mazurov, E. V. Zonova, O. B. Nesmeyanova, T. V. Plaksina, D. G. Krechikova, O. V. Reshetko, L. N. Denisov, I. G. Gordeev, T. G. Pokrovskaya, O. V. Antipova, T. V. Kropotina, T. V. Povarova, P. A. Shesternya, E. N. Ushakova, N. F. Soroka, A. M. Pristrom, A. V. Eremeeva, E. V. Chernyaeva, R. A. Ivanov, U. V. Usacheva
Published 2017-09-01Get full text
Article -
19
COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055 AND REFERENCE INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF THE IN... by A. M. Lila, V. I. Mazurov, E. V. Zonova, O. B. Nesmeyanova, T. V. Plaksina, D. G. Krechikova, O. V. Reshet’ko, L. N. Denisov, I. G. Gordeev, T. G. Pokrovskaya, O. V. Antipova, T. V. Kropotina, T. V. Povarova, P. A. Shesternya, E. N. Ushakova, N. F. Soroka, E. V. Kunder, A. V. Eremeeva, E. V. Chernyaeva, R. A. Ivanov, P. S. Pukhtinskaya
Published 2018-07-01Get full text
Article -
20
Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (... by Sh. Erdes, V. I. Mazurov, T. V. Dubinina, I. Z. Gaydukova, S. A. Lapshina, E. V. Zonova, D. G. Krechikova, T. V. Plaksina, O. V. Reshetko, S. A. Smakotina, P. А. Shesternya, I. G. Gordeev, T. G. Makulova, T. V. Povarova, T. A. Raskina, N. F. Soroka, A. M. Pristrom, E. V. Kunder, Yu. V. Usacheva, E. Yu. Stukalina, A. V. Eremeeva, E. V. Chernyaeva, R. A. Ivanov
Published 2019-12-01Get full text
Article